These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29804817)

  • 1. Metformin and risk of chronic obstructive pulmonary disease in diabetes patients.
    Tseng CH
    Diabetes Metab; 2019 Apr; 45(2):184-190. PubMed ID: 29804817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reduces risk of varicose veins in patients with type 2 diabetes.
    Tseng CH
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3206. PubMed ID: 31322821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Tseng CH
    Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
    Tseng CH
    Int J Chron Obstruct Pulmon Dis; 2022; 17():285-295. PubMed ID: 35177899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
    Tseng CH
    J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
    Chin-Hsiao T
    Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
    Tseng CH
    BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
    Tseng CH
    Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.